Actively Recruiting

Phase Not Applicable
Age: 40Years - 65Years
All Genders
ID06763601

Effect of Shoulder Symptom Modification Procedure (SSMP) in Managing Patients with Frozen Shoulder: a Pilot Study

Led by Gulf Medical University · Updated on 2025-01-08

36

Participants Needed

1

Research Sites

7 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating different treatment approaches for patients with frozen shoulder, aiming to improve shoulder function, reduce pain, and increase range of motion. The study compares the effects of Shoulder Symptom Modification Procedure (SSMP), Mobilization With Movement (MWM), and sham mobilization to determine which provides the most effective results. Participants are randomly assigned to one of three groups: one receiving SSMP followed by a series of exercises including isometric, eccentric, heavy slow resistance, and functional programs; another receiving MWM followed by the same exercise progression; and a third receiving sham mobilization as a placebo followed by the same exercise routine. The study timeline includes evaluation up to 8 weeks with various outcome measures. During the study, participants will be assessed using the Shoulder Pain and Disability Index and Numeric Pain Rating Scale at enrollment and weeks 4, 6, and 8. Additional measurements include range of motion at these weeks and a Patient's Global Impression of Change scale at enrollment and week 8. The study involves scheduled exercises and monitoring to track progress and response to the interventions.

CONDITIONS

Brief Title

Effect of Shoulder Symptom Modification Procedure (SSMP) in Managing Patients with Frozen Shoulder

Who Can Participate

Age: 40Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of adhesive capsulitis confirmed by a healthcare professional
  • Scores more than 2 in adhesive capsulitis scale
  • Range of motion affected in capsular pattern
  • Age between 40-65 years
  • Willingness to participate by signing informed consent
Not Eligible

You will not qualify if you...

  • History of shoulder dislocation
  • History of humerus fractures or trauma
  • Diagnosed with any sort of cancer
  • History of cardiovascular disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 8 weeks

Participants receive one of three procedures involving phases of symptom modification or mobilization followed by isometric exercises, eccentric training, heavy slow resistance exercises, and a functional program over 8 weeks.

Weekly visits for up to 8 weeks

Trial Site Locations

Total: 1 location

1

Thumbay Physical Therapy and Rehabilitation Hospital

Ajman, United Arab Emirates

Actively Recruiting

Loading map...

Research Team

A

Ayesha seemab, BPT

W

Watson Watson Arulsingh, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Effect of 3-Dimensional Shoulder Complex Pain Alignment (3-D...

Frozen Shoulder

Actively Recruiting

1 location

Adhesive Capsulitis: Prospective Analysis of Efficacy and Fi...

Adhesive Capsulitis

Actively Recruiting

1 location

Comparative Effectiveness of High-Intensity Laser Therapy Ve...

Frozen Shoulder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Effectiveness of shoulder symptom modification approaches in managing patients with frozen shoulder: study protocol for a randomized sham-controlled trial.

Ayesha Seemab, Watson Arulsingh, Ramprasad Muthukrishnan...

https://pubmed.ncbi.nlm.nih.gov/41992361